Loading...
XPAR
AI
Market cap120bUSD
Sep 17, Last price  
165.24EUR
1D
-0.71%
1Q
0.66%
Jan 2017
72.04%
Name

L'Air Liquide Societe Anonyme pour l'Etude et l'Exploitation des Procedes Georges Claude SA

Chart & performance

D1W1MN
XPAR:AI chart
P/E
31.09
P/S
4.06
EPS
5.31
Div yield, %
1.82%
Shrs. gr., 5y
2.03%
Rev. gr., 5y
4.78%
Revenues
25.88b
-4.36%
10,948,700,00011,801,200,00013,103,100,00011,976,100,00013,488,000,00014,456,900,00015,326,300,00015,414,500,00015,586,500,00015,818,500,00018,134,800,00020,349,300,00021,011,100,00021,920,100,00020,485,200,00023,334,800,00029,934,000,00027,607,600,00027,057,800,00025,876,942,875
Net income
3.38b
+2.21%
1,002,300,0001,123,100,0001,220,000,0001,230,000,0001,403,600,0001,534,900,0001,591,100,0001,640,300,0001,665,000,0001,756,400,0001,842,500,0002,233,300,0002,113,400,0002,241,500,0002,435,100,0002,572,200,0002,758,800,0003,078,000,0003,306,100,0003,379,057,963
CFO
6.10b
-3.45%
1,766,700,0002,102,100,0002,292,900,0002,451,800,0002,419,900,0002,425,800,0002,708,500,0002,802,700,0002,829,600,0002,832,400,0003,696,500,0004,254,000,0004,716,400,0004,490,900,0005,205,700,0005,570,700,0005,810,100,0006,263,000,0006,322,200,0006,103,993,161
Dividend
May 18, 20263.7 EUR/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Established in Paris, France, in 1902, L'Air Liquide S.A. is a prominent global supplier of industrial and medical gases, cutting-edge technologies, and specialized services. Its extensive operations cover Europe, the Americas, Asia Pacific, the Middle East, and Africa, catering to both industrial and healthcare sectors. The Gas & Services division provides a wide array of fundamental industrial gases, including oxygen, nitrogen, argon, and hydrogen, to key industries such as metallurgy, chemicals, refining, and energy. It also serves manufacturing, automotive, food and pharmaceuticals, technology and research, and retail with gases, associated equipment, and support services. For the healthcare sector, this segment delivers medical gases, hygiene solutions, equipment, and services to hospitals and patients receiving in-home care. Furthermore, it manufactures specialty ingredients for the cosmetics, pharmaceutical, and vaccine industries, and supplies crucial gases and materials for producing semiconductors, flat screens, and photovoltaic panels. The Engineering & Construction segment focuses on designing, developing, and constructing industrial gas production facilities for third parties, in addition to engineering and building plants for conventional, renewable, and alternative energy applications. Lastly, the Global Markets & Technologies segment drives innovation in the energy transition by offering technological solutions, encompassing molecules, equipment, and services. These initiatives support sustainable transport, energy generation, and waste valorization, alongside advancing deep technology in fields such as space exploration, aerospace, and major scientific projects. This segment actively invests in biomethane production, develops infrastructure for natural bio-gas and hydrogen distribution to promote clean mobility, manages biomethane production units for the maritime sector, and supplies gases to offshore oil and gas platforms, wind turbines, and for cryogenic transportation by sea.

Related entities

Subsidiaries (98)
AIR LIQUIDE MEDICAL SYSTEMS S.R.L.
Air Liquide Mexico, S. de R.L. de C.V.
Air Liquide Nederland B.V.
AIR LIQUIDE NEW ZEALAND LIMITED
AIR LIQUIDE OIL AND GAS SERVICES LIMITED
AIR LIQUIDE POLSKA SPOLKA Z OGRANICZONA ODPOWIEDZIALNOSCIA
AIR LIQUIDE RUSSIE
AIR LIQUIDE SANTE INTERNATIONAL
Air Liquide Servicios, S. de R.L. de C.V.
AIR LIQUIDE SPATIAL GUYANE
AIR LIQUIDE UK LIMITED
AIR LIQUIDE USA LLC
Air Liquide VietNam Company Limited
AKCIONERNOE OBSESTVO "ER LIKID SEVERSTAL"
AL AIR LIQUIDE ESPANA SA
ALIZENT INTERNATIONAL
AMERICAN AIR LIQUIDE HOLDINGS, INC.
AZERUS SAS
CARBAGAS AG
Celki International Limited

Key people

Chairman of the Board, Chief Executive Officer and Member of the Executive Committee · since 2006
Executive Vice President, in charge of Finance, Operations Control and General Secretariat, Member of the Executive Committee · since 2017
Executive Vice President supervising America, Asia Pacific hubs and Electronics World Business Line, Member of the Executive Board · since 2019
Francois Jackow
Executive Vice President supervising Europe Industries, Europe Healthcare, Africa/Middle East & India hubs, Healthcare World Business Line, Member of the Executive Committee · since 2019
Armelle Levieux
Vice President of Group Human Resources, Member of the Executive Committee · since 2017
Emilie Mouren-Renouard
Member of the Executive Committee, Head of Digital & IT, Intellectual Property, Global Markets and Technologies Activity · since 2019
Senior Vice President - Strategy. Member of the Executive Committee
Lead Independent Director · since 2017
Philippe Dubrulle
Director representing the employees · since 2014
Director · since 2017
Director · since 2017
Independent Director · since 2015
Independent Director · since 2016
Independent Director · since 2011
Independent Director · since 2017
IPO date
Feb 20, 1913
Employees
67,100
Domiciled in
FR
Incorporated in
FR
Headquarters & legal address
75 QUAI D'ORSAY
PARIS 75007
FR

Valuation

Title
EUR in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT